Is biote Corp. (BTMD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 123.6% / 30% | 43.8% / 30% | 8.6% / 30% | 9.94% / 5% | ✗ NOT HALAL |
| DJIM | 123.6% / 33% | 43.8% / 33% | 8.6% / 33% | 9.94% / 5% | ✗ NOT HALAL |
| MSCI | 90.6% / 33% | 32.2% / 33% | 6.3% / 33% | 9.94% / 5% | ✗ NOT HALAL |
| S&P | 123.6% / 33% | 43.8% / 33% | 8.6% / 33% | 9.94% / 5% | ✗ NOT HALAL |
| FTSE | 90.6% / 33% | 32.2% / 33% | 6.3% / 50% | 9.94% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 71.5% | |
| Operating Margin | 9.4% | |
| Net Margin | 14.1% | |
| Return on Assets (ROA) | 19.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $35M |
| Free Cash Flow | $28M |
| Total Debt | $110M |
| Current Ratio | 1.2 |
| Total Assets | $108M |
Price & Trading
| Last Close | $1.35 |
| 50-Day MA | $1.95 |
| 200-Day MA | $2.88 |
| Avg Volume | 194K |
| Beta | 1.1 |
|
52-Week Range
$1.27
| |
About biote Corp. (BTMD)
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is biote Corp. (BTMD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), biote Corp. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is biote Corp.'s debt ratio?
biote Corp.'s debt ratio is 123.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 90.6%.
What are biote Corp.'s key financial metrics?
biote Corp. has a market capitalization of $58M, trailing P/E ratio of 1.8, and revenue of $192M. The company maintains a gross margin of 71.5% and a net margin of 14.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.